Protease-Activated Receptor-3 (PAR-3) (1-6), human (TFA)

Protease-Activated Receptor-3 (PAR-3) (1-6), human (TFA)

• UNSPSC Description: Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA is a proteinase-activated receptor (PAR-3) agonist peptide[1].
• Target Antigen: Protease Activated Receptor (PAR)
• Type: Peptides
• Related Pathways: GPCR/G Protein
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/protease-activated-receptor-3-par-3-1-6-human-tfa.html
• Purity: 99.86
• Solubility: H2O : 100 mg/mL (ultrasonic)
• Smiles: O=C([C@@H](N)[C@@H](C)O)N[C@H](C(N[C@H](C(NCC(N[C@H](C(N1[C@H](C(N)=O)CCC1)=O)C)=O)=O)CCCNC(N)=N)=O)CC2=CC=CC=C2.O=C(O)C(F)(F)F
• Molecular Weight: 760.76
• References & Citations: [1]inase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein. Pancreas. 2014 Jan; 43(1): 10.1097/MPA.0b013e31829f0b81.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported